The Application Notebook
In the past decade, supercritical fluid chromatography (SFC) has experienced a steady growth in acceptance, particularly in pharmaceutical and chemical laboratories. In SFC, "supercritical" CO2 combined with one or more polar organic solvents, most commonly alcohols, are used as mobile phase. Preparative SFC is deemed by many to hold the greatest promise to attain mainstream acceptance. The reduction in solvent consumption and collection in relatively small volumes of volatile organic solvents, hence, a much less stringent post-purification endeavour, lead to significant savings on operation costs. For example, Ripka et al. calculated that 20000 samples purified by SFC instead of reverse phase liquid chromatography (RPLC) would realize a 48 times reduction in solvent consumption.1
Andreas Mich,1 Burkhard Matthes,1 Rui Chen2 and Stefan Buehler1
1Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany,
2Waters Corporation, Newark Delaware, USA.
In the past decade, supercritical fluid chromatography (SFC) has experienced a steady growth in acceptance, particularly in pharmaceutical and chemical laboratories. In SFC, "supercritical" CO2 combined with one or more polar organic solvents, most commonly alcohols, are used as mobile phase. Preparative SFC is deemed by many to hold the greatest promise to attain mainstream acceptance. The reduction in solvent consumption and collection in relatively small volumes of volatile organic solvents, hence, a much less stringent post-purification endeavour, lead to significant savings on operation costs. For example, Ripka et al. calculated that 20000 samples purified by SFC instead of reverse phase liquid chromatography (RPLC) would realize a 48 times reduction in solvent consumption.1
Mass-directed RPLC has revolutionized the workflow for chemists in drug discovery by enabling one fraction collection per injection, largely owing to the specificity that MS detection can offer. A mass-directed preparative SFC system, like its counterpart in RPLC, will certainly be welcomed by the industry for high throughput purification of diverse libraries of drug-like compounds.2 However, open bed fraction collection has been a challenge for SFC as result of aerosol formation caused by the depressurization of CO2, particularly at high flow rates. Zhang et al. demonstrated the feasibility of MS-directed SFC fraction collection, but it was limited to flow rates of 30 mL/min.3 The challenge of managing aerosols in collection at high flow rates has been overcome with the development of the Waters TharSFC SFC-MS Prep 100 system.4
In this application note, we present a comparative study of the mass-directed purification of 167 library compounds by both AutoPurification LC–MS and Waters TharSFC SFC-MS Prep 100. The success rates of each technique individually and the two techniques combined are compared to highlight the orthogonality of these techniques.
The library compounds were synthesized by the combinatorial chemistry group at Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. A detailed description of the SFC-MS Prep 100 system can be found elsewhere.4 Key experimental parameters are listed in Table 1.
Table 1: Key experimental parameters in this study.
Figure 1 shows the representative chromatograms where both techniques were successful in collecting the desired compound. However, the chromatograms from RPLC and SFC are different, indicating the different selectivity between RPLC and SFC. Supercritical fluid chromatography is generally considered a normal phase separation technique that complements reverse phase LC in selectivity, especially for polar compounds and structurally similar compounds.5 In addition, the mobile phase for SFC was supercritical CO2 and methanol, and for RPLC, water and methanol were used. The two mobile phases possess different solvent strength, resulting in substantially different sample loading capacity depending on the nature of the compounds. The combination of RPLC and SFC will cover a wider sample polarity range, typical for library compounds, than each technique alone.
Figure 1
Table 2 summarizes the comparison between the two techniques for the purification of the two libraries. Note that the registered compound is defined as the compound purified from raw mixtures that meets three predefined criteria: (1) > 2 mg; (2) purity > 80% by LC PDA; and (3) purity > 80% by NMR. Overall, both techniques display similar performance in terms of success rate and purity. The success rate for SFC was 27%, 25% for RPLC and 32% when both techniques were combined, representing a 30% increase from each technique alone. It has to be pointed out that the overall 68% "failure" rate is not the true reflection of either purification technique. The pre-analysis indicated that the syntheses were not successful for more than 60% of the library compounds.
Table 2: Comparison on the purification of the two libraries between RPLC and SFC.
The batch time for SFC was 20% shorter than for RPLC. This gain in throughput is mainly due to the shorter dry-down time post-purification in SFC than in RPLC. It is also noted that for SFC, a generic gradient from 5–30% with a cycle time of 11 min was used, whereas for RPLC, a focused gradient of 23–43% was used based on the preceding analytical scouting experiments. It is envisioned that the batch cycle time for SFC can be further reduced by applying a similar focused-gradient approach. More work to optimize the work flow is currently under way.
With the economic downturn and patents coming off protection in the next few years, improving productivity and more aggressive cost-savings have become top priorities in the pharmaceutical industry. In addition to the evident cost-savings as a result of higher throughput and less post-purification endeavour, the orthogonality of SFC to RPLC also provides chemists with the capability to recover more compounds from medicinal chemistry, which already has significant embedded capital investment, for ensuing research and development.
The success rate of purifying the raw mixtures to registered compounds was 27% for SFC and 25% for RPLC. The combination of the two techniques resulted in an overall increase in success rate by roughly 30% compared to using each technique alone, mainly because of the orthogonality between the two techniques. Despite using a longer gradient cycle in SFC, overall batch processing time for SFC was 20% less than RPLC. This gain in throughput was the result of shorter dry-down time post-purification.
1. William C. Ripka, Geoffrey Barker and Jonathan Krakover, Drug Discovery Today, 6(9), 471–477 (2001).
2. Ray T. McClain et al., Journal of Liquid Chromatography & Related Technologies, 32, 483–499 (2009).
3. Xu Zhang et al., Journal of Combinatorial Chemistry, 8, 705–714 (2006).
4. Christine Aurigemma et al., poster presentation, LabAutomation, Palm Springs, California, USA (2009).
5. Y. Zhao et al., LCGC Eur., 17, 224–238 (2004).
TharSFC, a Waters Company
575 Epsilon Drive — Suite 100, Pittsburgh, Pennsylvania 15238, USA
tel. +1 412 967 5665 fax +1 412 967 9446
E-mail: info@tharsfc.com
Website: www.waters.com/sfc
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.